Press release
August 4, 2026
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Tiziana Life Sciences Ltd (TLSA)
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody,